Guus Bol, MD, PhD

Title(s)HS Asst Clinical Professor, Medicine
SchoolSchool of Medicine
Address550 16th Street, #6663
San Francisco CA 94158
ORCID ORCID Icon0000-0002-4021-3823 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Radiation Lobectomy in Adjunct to Double Vein Embolization to Reach Sufficient Future Liver Remnant in Patients with Colorectal Cancer Liver Metastases: A Case Series. Cardiovasc Intervent Radiol. 2024 Nov 27. Andel D, Ramdhani K, Braat AJAT, Bruijnen RCG, Bol G, Keane G, Lam MGEH, Kranenburg OW, Rinkes IHMB, Hagendoorn J, Smits MLJ. PMID: 39604694.
      View in: PubMed   Mentions:    Fields:    
    2. Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with less than 10 metastases: A multicenter pilot study (NCT05375708). Clinical and Translational Radiation Oncology. 2024; 49:100874. K. Zwart, M. Braat, F. van der Baan, A. May, J. Roodhart, D. Al-Toma, J. Otten, M. Los, T. Oostergo, R. Fijneman, J. van Dodewaard-de Jong, C. Punt, G. Meijer, J. Lagendijk, M. Koopman, M. Intven, G. M. Bol. . View Publication.
    3. Targeting RNA helicase DDX3X with a small molecule inhibitor for breast cancer bone metastasis treatment. Cancer Lett. 2024 Nov 01; 604:217260. Winnard PT, Vesuna F, Bol GM, Gabrielson KL, Chenevix-Trench G, Ter Hoeve ND, van Diest PJ, Raman V. PMID: 39306228.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    4. Ablation of Small Liver Metastases Presenting as Foci of Diffusion Restriction on MRI-Results from the Prospective Minimally Invasive Thermal Ablation (MITA) Study. Cancers (Basel). 2024 Jun 29; 16(13). Wijnen N, Bruijnen RCG, Thelissen AAB, de Jong HWAM, van Leeuwaarde RS, Hagendoorn J, Bol GM, Smits MLJ. PMID: 39001471; PMCID: PMC11240348.
      View in: PubMed   Mentions:
    5. Conventional versus Hepatic Arteriography and C-Arm CT-Guided Ablation of Liver Tumors (HepACAGA): A Comparative Analysis. Cancers (Basel). 2024 May 18; 16(10). Wijnen N, Bruijnen RCG, Vonken EPA, de Jong HWAM, de Bruijne J, Bol GM, Hagendoorn J, Intven MPW, Smits MLJ. PMID: 38792003; PMCID: PMC11119442.
      View in: PubMed   Mentions: 1  
    6. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand? Curr Treat Options Oncol. 2024 Apr; 25(4):405-426. van Nassau SCMW, Bol GM, van der Baan FH, Roodhart JML, Vink GR, Punt CJA, May AM, Koopman M, Derksen JWG. PMID: 38367182; PMCID: PMC10997699.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Lung Mean Dose Prediction in Transarterial Radioembolization (TARE): Superiority of [166Ho]-Scout Over [99mTc]MAA in a Prospective Cohort Study. Cardiovasc Intervent Radiol. 2024 Apr; 47(4):443-450. Wagemans MEHM, Braat AJAT, van Rooij R, Smits MLJ, Bruijnen RCG, Prince JF, Bol GM, de Jong HWAM, Lam MGEH. PMID: 38326577; PMCID: PMC10997535.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Stromal localization of inactive CD8+ T cells in metastatic mismatch repair deficient colorectal cancer. Br J Cancer. 2024 Feb; 130(2):213-223. Küçükköse E, Baars MJD, Amini M, Schraa SJ, Floor E, Bol GM, Borel Rinkes IHM, Roodhart JML, Koopman M, Laoukili J, Kranenburg O, Vercoulen Y. PMID: 38042958; PMCID: PMC10803761.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    9. Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer. Virchows Arch. 2023 Jun; 482(6):983-992. Schraa SJ, Stelloo E, Laclé MM, Swennenhuis JF, Brosens LAA, Fijneman RJA, Feitsma H, Koopman M, de Leng WW, Vink GR, Bol GM. PMID: 37067589; PMCID: PMC10247849.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    10. Spontaneous Complete Regression of Colon Cancer Liver Metastases in a Lung Transplant Patient: A Case Report. Case Rep Transplant. 2023; 2023:9643370. Zwart K, Ruigrok D, de Graaf-Bos M, Goldschmeding R, Koopman M, Bol GM. PMID: 36685719; PMCID: PMC9851788.
      View in: PubMed   Mentions:
    11. Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by 68Ga-FAPI-PET imaging. Br J Cancer. 2022 Jul; 127(1):145-155. Strating E, Wassenaar E, Verhagen M, Rauwerdink P, van Schelven S, de Hingh I, Rinkes IB, Boerma D, Witkamp A, Lacle M, Fodde R, Volckmann R, Koster J, Stedingk K, Giesel F, de Roos R, Poot A, Bol G, Lam M, Elias S, Kranenburg O. PMID: 35296803; PMCID: PMC9276750.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    12. Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer. JAMA Netw Open. 2021 Sep 01; 4(9):e2124766. van Nassau SC, Bond MJ, Scheerman I, van Breeschoten J, Kessels R, Valkenburg-van Iersel LB, Verheul HM, Buffart TE, Mekenkamp LJ, Lemmens VE, Koopman M, Bol GM, EXCITE (From Clinical Trial to Bedside: Triplet Chemotherapy in Metastatic Colorectal Cancer) Study . PMID: 34505885; PMCID: PMC8433607.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Leerboek oncologie. ch. 12. paraneoplastische syndromen ch. 21. Tumoren van dunne en dikke darm. 2020. J. H. J. M. van Krieken, R. G. H. Beets-Tan, Gelderblom, M. J. J. O. van Acht, H. J. T. Rutten.
    14. Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation. Genes Cancer. 2019 Feb; 10(1-2):11-20. Kerr CL, Bol GM, Vesuna F, Raman V. PMID: 30899416; PMCID: PMC6420792.
      View in: PubMed   Mentions: 7  
    15. Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment. Oncogene. 2018 Jan 04; 37(1):63-74. Heerma van Voss MR, Vesuna F, Bol GM, Afzal J, Tantravedi S, Bergman Y, Kammers K, Lehar M, Malek R, Ballew M, Ter Hoeve N, Abou D, Thorek D, Berlinicke C, Yazdankhah M, Sinha D, Le A, Abrahams R, Tran PT, van Diest PJ, Raman V. PMID: 28869602; PMCID: PMC5756132.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    16. Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer. Onco Targets Ther. 2017; 10:3501-3513. Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V. PMID: 28761359; PMCID: PMC5522823.
      View in: PubMed   Mentions: 18  
    17. Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer. Med Oncol. 2017 Mar; 34(3):33. Heerma van Voss MR, Brilliant JD, Vesuna F, Bol GM, van der Wall E, van Diest PJ, Raman V, Heerma van Voss MR, Brilliant JD, Vesuna F, Bol GM, van der Wall E, van Diest PJ, Raman V. PMID: 28138868; PMCID: PMC5576028.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    18. RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3. Cancer Res. 2016 Nov 01; 76(21):6340-6350. Xie M, Vesuna F, Tantravedi S, Bol GM, Heerma van Voss MR, Nugent K, Malek R, Gabrielson K, van Diest PJ, Tran PT, Raman V. PMID: 27634756; PMCID: PMC5576499.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    19. FOLFOX chemotherapy as a cause of ventricular septal rupture after alcohol septal ablation for obstructive hypertrophic cardiomyopathy? Int J Cardiol. 2016 Mar 15; 207:208-10. Liebregts M, Bol GM, Groen JW, Lieuw-a-Fa M, Heijmen RH, ten Berg JM. PMID: 26803246.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. DDX3, a potential target for cancer treatment. Mol Cancer. 2015 Nov 05; 14:188. Bol GM, Xie M, Raman V. PMID: 26541825; PMCID: PMC4636063.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    21. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3. Oncotarget. 2015 Oct 06; 6(30):29901-13. Xie M, Vesuna F, Botlagunta M, Bol GM, Irving A, Bergman Y, Hosmane RS, Kato Y, Winnard PT, Raman V. PMID: 26337079; PMCID: PMC4745771.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    22. PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3. Cancer Chemother Pharmacol. 2015 Oct; 76(4):821-7. Bol GM, Khan R, Heerma van Voss MR, Tantravedi S, Korz D, Kato Y, Raman V. PMID: 26330329; PMCID: PMC4878412.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    23. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy. EMBO Mol Med. 2015 May; 7(5):648-69. Bol GM, Vesuna F, Xie M, Zeng J, Aziz K, Gandhi N, Levine A, Irving A, Korz D, Tantravedi S, Heerma van Voss MR, Gabrielson K, Bordt EA, Polster BM, Cope L, van der Groep P, Kondaskar A, Rudek MA, Hosmane RS, van der Wall E, van Diest PJ, Tran PT, Raman V. PMID: 25820276; PMCID: PMC4492822.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansAnimalsCells
    24. Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer. PLoS One. 2013; 8(5):e63548. Bol GM, Raman V, van der Groep P, Vermeulen JF, Patel AH, van der Wall E, van Diest PJ. PMID: 23696831; PMCID: PMC3656050.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    25. Epigenetic biomarkers in the diagnosis of ovarian cancer. Expert Opin Med Diagn. 2012 Sep; 6(5):421-38. Bijron JG, Bol GM, Verheijen RH, van Diest PJ. PMID: 23480807.
      View in: PubMed   Mentions: 4     Fields:    
    26. Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells. PLoS One. 2011 Mar 23; 6(3):e17563. Botlagunta M, Krishnamachary B, Vesuna F, Winnard PT, Bol GM, Patel AH, Raman V. PMID: 21448281; PMCID: PMC3063174.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    27. Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System. ACS Med Chem Lett. 2010 Dec 31; 2(3):252-256. Kondaskar A, Kondaskar S, Kumar R, Fishbein JC, Muvarak N, Lapidus RG, Sadowska M, Edelman MJ, Bol GM, Vesuna F, Raman V, Hosmane RS. PMID: 21572541; PMCID: PMC3092706.
      View in: PubMed   Mentions: 25  
    28. BRCA1 methylation and BRCA1 mutations in ovarian cancer. Gynecol Oncol. 2011 Aug; 122(2):459; author reply 459-60. Bol GM, van Diest PJ. PMID: 21194739.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    29. Methylation profiles of hereditary and sporadic ovarian cancer. Histopathology. 2010 Sep; 57(3):363-70. Bol GM, Suijkerbuijk KP, Bart J, Vooijs M, van der Wall E, van Diest PJ. PMID: 20840667.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    30. Homeless people in San Francisco. The Lancent Student. 2008. G.M. Bol. .
    Guus's Networks
    Concepts (150)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-8-gc1ed69da on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.